Capricor Therapeutics | CAPR - Selling And Administration Expenses

Stock Price
34.68
Daily Change
0.14 0.41%
Monthly
13.48%
Yearly
253.16%
Q2 Forecast
30.35

Capricor Therapeutics reported $1.92M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 1.45M 703.96K Dec/2025
Bioline Rx USD 831K 622K Sep/2025
Capricor Therapeutics USD 1.92M 446.47K Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Cytokinetics USD 91.72M 67.02M Dec/2025
Geron USD 41.67M 2.67M Dec/2025
Grifols EUR 320.45M 12.65M Dec/2025
Immunic USD -0.24 0.03 Sep/2024
J&J USD 6.75B 831M Dec/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Prothena USD 7.65M 5.59M Dec/2025
PTC Therapeutics USD 87.2M 3.15M Dec/2025
Sarepta Therapeutics USD 105.38M 28.27M Dec/2025